{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:33:56Z","timestamp":1773477236108,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.contraception.2009.07.011","type":"journal-article","created":{"date-parts":[[2009,9,12]],"date-time":"2009-09-12T08:16:27Z","timestamp":1252743387000},"page":"57-61","source":"Crossref","is-referenced-by-count":18,"title":["Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use"],"prefix":"10.1016","volume":"81","author":[{"given":"Inka","family":"Wiegratz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skadi","family":"Stahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Manthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"S\u00e4nger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Mittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesta","family":"Palombo-Kinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.07.011_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(98)00016-X","article-title":"Oral contraceptive use and myocardial infarction","volume":"57","author":"Petitti","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-7824(03)00073-8","article-title":"Oral contraceptive use and the risk of myocardial infarction: a meta-analysis","volume":"68","author":"Khader","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib3","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2009.07.011_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2009.07.011_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2009.07.011_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(98)00018-3","article-title":"Safety evaluation of modern oral contraceptives","volume":"57","author":"Crook","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.maturitas.2003.10.013","article-title":"Biology: risk factor modification by OCs and HRT lipids and lipoproteins","volume":"47","author":"Godsland","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2009.07.011_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tem.2004.06.006","article-title":"Progestogen therapies: differences in clinical effects?","volume":"15","author":"Wiegratz","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.contraception.2009.07.011_bib9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200464210-00006","article-title":"Long-cycle treatment with oral contraceptives","volume":"64","author":"Wiegratz","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2009.07.011_bib10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.011_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2003.09.004","article-title":"Attitudes of German women and gynecologists towards long-cycle treatment with oral contraceptives","volume":"69","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180600772741","article-title":"Metabolic and clinical effects of progestogens","volume":"11","author":"Kuhl","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.07.011_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0010-7824(01)00310-9","article-title":"Effect of dienogest-containing oral contraceptives on lipid metabolism","volume":"65","author":"Wiegratz","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0010-7824(90)90066-5","article-title":"Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 \u03bcg ethinylestradiol and 75 \u03bcg gestodene or 150 \u03bcg desogestrel","volume":"41","author":"M\u00e4rz","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib15","first-page":"666","article-title":"Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism","volume":"78","author":"Rubeck Petersen","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.07.011_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0010-7824(92)90103-Z","article-title":"A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel","volume":"45","author":"Song","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin\u2013aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2009.07.011_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000184610","article-title":"Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 \u03bcg ethinylestradiol and 150 \u03bcg desogestrel or 3-keto-desogestrel","volume":"44","author":"Kuhl","year":"1995","journal-title":"Horm Res"},{"key":"10.1016\/j.contraception.2009.07.011_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0010-7824(98)00074-2","article-title":"Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters","volume":"58","author":"Wiegratz","year":"1998","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2009.07.011_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625189909085267","article-title":"A comparative study of the effects of gestodene 60 \u03bcg\/ethinylestradiol 15 \u03bcg and desogestrel 150 \u03bcg\/ethinylestradiol 20 \u03bcg on hemostatic balance, blood lipid levels and carbohydrate metabolism","volume":"4","author":"van der Mooren","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.07.011_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(00)00196-7","article-title":"Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel","volume":"63","author":"Knopp","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 \u03bcg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2009.07.011_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/09513599609045648","article-title":"Inhibition of low-density lipoprotein oxidation in vitro and ex vivo by several estrogens and oral contraceptives","volume":"10","author":"Wiegratz","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2009.07.011_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0010-7824(94)90051-5","article-title":"Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive","volume":"50","author":"Cachrimanidou","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.07.011_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.contraception.2004.06.001","article-title":"Clinical and metabolic aspects of the continuous use of contraceptive association of ethinyl estradiol (30 \u03bcg) and gestodene (75 \u03bcg)","volume":"70","author":"Bonassi Machado","year":"2004","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409003564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T07:00:08Z","timestamp":1545030008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409003564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0010782409003564"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.07.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}